SG46640A1 - Peptides with an insulin like action - Google Patents

Peptides with an insulin like action

Info

Publication number
SG46640A1
SG46640A1 SG1996006947A SG1996006947A SG46640A1 SG 46640 A1 SG46640 A1 SG 46640A1 SG 1996006947 A SG1996006947 A SG 1996006947A SG 1996006947 A SG1996006947 A SG 1996006947A SG 46640 A1 SG46640 A1 SG 46640A1
Authority
SG
Singapore
Prior art keywords
residue
insulin
acid residue
alkyl
hydrogen atom
Prior art date
Application number
SG1996006947A
Other languages
English (en)
Inventor
Wendelin Frick
Gunter Muller
Stefan Mullner
Gerhard Breipohl
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SG46640A1 publication Critical patent/SG46640A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996006947A 1991-11-29 1992-11-23 Peptides with an insulin like action SG46640A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4139376 1991-11-29

Publications (1)

Publication Number Publication Date
SG46640A1 true SG46640A1 (en) 1998-02-20

Family

ID=6445910

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996006947A SG46640A1 (en) 1991-11-29 1992-11-23 Peptides with an insulin like action

Country Status (11)

Country Link
US (1) US5622934A (ja)
EP (1) EP0545198B1 (ja)
JP (1) JP3324804B2 (ja)
AT (1) ATE184611T1 (ja)
DE (1) DE59209745D1 (ja)
DK (1) DK0545198T3 (ja)
ES (1) ES2137937T3 (ja)
FI (1) FI925370A (ja)
GR (1) GR3031850T3 (ja)
NO (1) NO309146B1 (ja)
SG (1) SG46640A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19512484A1 (de) 1995-04-04 1996-10-17 Bayer Ag Kohlenhydratmodifizierte Cytostatika
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
KR100481746B1 (ko) * 1996-11-28 2005-08-10 훽스트 악티엔게젤샤프트 인슐린-유사작용을갖는이노시톨글리칸및이를포함하는약제학적제제
DE19649350A1 (de) * 1996-11-28 1998-06-04 Hoechst Ag Inositolglykane mit insulinartiger Wirkung
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
NZ576285A (en) 2006-10-12 2012-02-24 Bellus Health International Ltd Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
US4515920A (en) * 1984-04-30 1985-05-07 The Rockefeller University Synthesis of peptides and proteins
DE3769910D1 (de) * 1986-10-24 1991-06-13 Pfrimmer Kabi Gmbh & Co Kg Verwendung von n, n'-bis-l-aminosaeure-l-cystinpeptiden in aminosaeure-praeparaten fuer orale und parenterale ernaehrung.
FI881869A (fi) * 1987-04-25 1988-10-26 Hoechst Ag Enkastiner: nya glykopeptider med enkefalinashindrande verkan, foerfaranden foer deras framstaellning och deras anvaendning saosom farmaceutiska produkter.
US5539084A (en) * 1989-02-17 1996-07-23 Coselco Mimotopes Pty. Ltd. Method for the use and synthesis of peptides
KR950001634B1 (ko) * 1989-11-27 1995-02-27 산뗑세이야꾸 가부시기가이샤 아미노산 유도체
TW227004B (ja) * 1990-12-19 1994-07-21 Hoechst Ag
YU66892A (sh) * 1991-08-20 1995-10-24 Hoechst Ag. Fosfoinositolglikan - peptid sa delovanjem kao insulin

Also Published As

Publication number Publication date
JP3324804B2 (ja) 2002-09-17
FI925370A (fi) 1993-05-30
FI925370A0 (fi) 1992-11-26
GR3031850T3 (en) 2000-02-29
NO924585D0 (no) 1992-11-27
EP0545198A2 (de) 1993-06-09
DE59209745D1 (de) 1999-10-21
JPH05247088A (ja) 1993-09-24
DK0545198T3 (da) 2000-03-20
NO924585L (no) 1993-06-01
EP0545198B1 (de) 1999-09-15
NO309146B1 (no) 2000-12-18
EP0545198A3 (ja) 1994-03-23
ATE184611T1 (de) 1999-10-15
ES2137937T3 (es) 2000-01-01
US5622934A (en) 1997-04-22

Similar Documents

Publication Publication Date Title
ES2018635A6 (es) Procedimiento de obtencion de adhesivos polisonizados metabolicamente aceptables.
AU564648B2 (en) Insulin agent
AU1022892A (en) Dental/medical composition and use
AU4149489A (en) Polyurethanes and their manufacture
ES8504678A1 (es) Procedimiento para la preparacion de un derivado de insulina
ATE196298T1 (de) Oberflächenaktives lungenprotein und verwandte polypeptide
GR3032905T3 (en) Use of halogenated hydrocarbon solvents.
MY102585A (en) N-cyanoisothioureas and use thereof in pest control
SG46640A1 (en) Peptides with an insulin like action
CA2004991A1 (en) Deletion analogues of magainin peptides
KR890012929A (ko) 2개의 방향족 환 함유 화합물의 디아실화 방법
NZ241029A (en) Peptides with cysteine residue or dimers thereof with insulin activity and pharmaceutical compositions
IL111361A0 (en) Pharmaceutical compositions for the treatment of insulin dependent diabetes mellitus (iddm)
ATE87939T1 (de) Glycosylierte aminosaeuren und peptide.
ATE102953T1 (de) Retro-inverso-thrymopentin-analoge, verfahren zu deren herstellung und deren verwendung fuer die zubereitung von pharmazeutischen zusammensetzungen.
IL119526A (en) Preparations comprising T cells for prevention or treatment of insulin dependent diabetes mellitus (IDDM)